STEPHEN WRIGHT: Open Payments
NPI 1235143439 · LAPEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,378 in 103 payments from 24 companies in 2025. Trend: 2023 $1,898 · 2024 $1,710 · 2025 $2,378
Food & beverage: $2,313Education: $65
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $373 |
| Novo Nordisk Inc | 14 | $301 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $249 |
| PFIZER INC. | 16 | $186 |
| Amgen Inc. | 13 | $162 |
| Inspire Medical Systems, Inc. | 2 | $161 |
| Axsome Therapeutics, Inc. | 3 | $138 |
| Medtronic, Inc. | 2 | $113 |
| Lilly USA, LLC | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
Products named: BREZTRI, Kerendia, Wegovy, OTEZLA, INSPIRE, Auvelity, AIRSUPRA, INTELLIS ADAPTIVESTIM.
Industry payments across IN — which companies pay providers there.
